MedTrace Logo

Dosage of Epidural Morphine in Elderly Patients

NCT04316871 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2025-03-05

Study results available
· View outcomes & findings →

Summary

This a clinical trial that evaluates the efficacy and safety of three different doses of morphine, namely 1.5 mg, 3 mg and 4.5 mg, via the epidural route regarding reducing pain in elderly patients after a cancer surgery in the lower abdomen

Conditions

  • Age Problem
  • Abdominal Cancer

Interventions

DRUG

1.5 mg of Morphine Sulfate

1.5 mg of Morphine Sulphate will be given epidurally.

DRUG

Normal saline

Normal saline will be given epidurally.

DRUG

3 mg of Morphine Sulfate

3 mg of Morphine Sulphate will be given epidurally.

DRUG

4.5 mg of Morphine Sulfate

4.5 mg of Morphine Sulphate will be given epidurally.

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Diab Hetta, MD · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-20
Primary Completion
2020-12-31
Completion
2021-06-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04316871 on ClinicalTrials.gov